Speaker Profile
DO, Associate Center Director of Experimental Therapeutics, Yale U.
Biography
Dr. Patricia LoRusso has been a practicing academic medical oncologist performing clinicaltranslational research in early phase clinical trials for 30 years, spending the first 25 years at Wayne State UniversityKarmanos Cancer Institute in Detroit, MI and transitioning to Yale UniversityYale Cancer Center in 2014. Both institutions have NCI comprehensive designation status.
Session Abstract – PMWC 2024 Silicon Valley
Track 3 - January 24 9.00 A.M.-4.30 P.M.
Track Chair: Razelle Kurzrock, Medical College of Wisconsin
- PMWC 2024 Award Ceremony:
Luminary Honoree: Catriona Jamieson, UCSD Health
- Targeting Cancer Stem Cells in Precision Oncology
- Catriona Jamieson, UCSD Health
- Revolutionizing Clinical Trials: Precision Oncology and Novel Trial Designs (PANEL)
Chair: Razelle Kurzrock, MCW
- Vivek Subbiah, Sarah Cannon Research Institute (SCRI)
- Andrea Cercek, Memorial Sloan Kettering
- Ben George, MCW
- Patricia LoRusso, Yale - Transcriptomics in Precision Oncology: Opportunities and Limitations (PANEL)
Chair: Razelle Kurzrock, MCW
- Charles Perou, University of North Carolina
- Eytan Ruppin, NIH
- Bruce Quinn, Bruce Quinn Assoc LL
- Andrea Califano, Columbia University - Democratizing Access to Personalized Cancer Care: The Role of Biomarker Testing (PANEL)
Chair: Maggie Rougier-Chapman, Labcorp
- Antibody-Drug Conjugates (ADCs): Tracing the Evolution and Forecasting the Future (PANEL)
Chair: Adrian Lee, UPMC
- Sandhya Girish, Gilead
- Neelima Denduluri, Astra Zeneca
- Hope S. Rugo, UCSF - PMWC Showcase
- Michael Milburn, Genecentric Tx
